New vaccine boosts India's bid to become low-cost lab of the world

Thu, Mar 12, 2015 - 5:50 AM

New Delhi

INDIA has long been known as a country that knows how to reproduce generic versions of patented drugs at lower cost.

This week it broke new ground when it unveiled the first indigenously developed vaccine against a diarrhoea-causing virus that is one of the leading causes

Rotavirus
Bharat Biotech
Vaccine Action Programme
halal vaccine

Breaking News

12:10 am

Saudi oil exports to drop by about 100,000bpd in Aug- Opec governor

12:02 am

Richter CEO stops stock rout saying drugmaker in sound shape

11:50 pm

Latest Earnings

11:45 pm

Paulson to call for Detour shareholders meeting to change board

11:30 pm

Aviation industry urged to hire more women as staff shortages loom

11:15 pm

De Beers makes rare acquisition by buying Canadian diamond mine

1	Wheelock Properties parent offers S$2.10 per share to privatise developer; stock hits S$2.19
2	Malaysia appoints Singapore law firm to start 1MDB legal action against 53 individuals and companies
3	Cooling measures raised homeownership costs, cooled property demand: Redas president
4	Impact of latest curbs has Redas seminar abuzz
5	Singapore banks clear up on coal lending policies

Consumer

Consumer

You are here

New vaccine boosts India's bid to become low-cost lab of the world

Privatisation bid for Wheelock could boost other developer stocks

Investors lament lack of progress on Hyflux revamp, Tuaspring sale

Given a second chance, die-hard Vard shareholders must come out to vote

Must Read

Privatisation bid for Wheelock could boost other developer stocks

Investors lament lack of progress on Hyflux revamp, Tuaspring sale

Fresh grads' woes examined in BT Weekend

Productivity is a better tool to fight business costs: Hong Tat

You are here

New vaccine boosts India's bid to become low-cost lab of the world

Market voices on:

Sign up for BT Newsletters

Editor's Choice

Most Read

Must Read